The impact of adenosine and A2B receptors on glucose homoeostasis

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 12, 2006, Pages 1639-1645

  Rusing D ^a   Muller C E ^b   Verspohl, E J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; N6 3 CYCLOHEXYLADENOSINE; PSB 1115; PSB 53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; NONHUMAN; RAT; WISTAR RAT;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD GLUCOSE; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOMEOSTASIS; INSULIN; MALE; PHENETHYLAMINES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; SULFONIC ACIDS; XANTHINES;

EID: 33846024054     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.12.0011     Document Type: Article

References (20)

1. Abo-Salem, O. M., Hayallah, A. M., Bilkei-Gorzo, A., Filipek, B., Zimmer, A., Müller, C. E. (2004) Antinociceptive effects of novel A2B adenosine receptor antagonists. J. Pharmacol. Exp. Ther. 308: 358-366
2. Arias, A. M., Bisschop, P. H., Ackermans, M. T., Nijpels, G., Endert, E., Romijn, J. A., Sauerwein, H. P. (2001) Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus. Metabolism 50: 1030-1035
3. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A., Wollheim, C. B. (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130: 167-178
4. Bacher, S., Kraupp, O., Conca, W., Raberger, G. (1982) The effects of NECA (adenosine-5′N-ethylcarboxamide) and of adenosine on glucagon and insulin release for the in situ isolated blood-perfused pancreas in anesthetized dogs. Naunyn-Schmledberg's Arch. Pharmacol. 320:67-71
5. Battrons, R., Van Schaftingen, E., Hers, H. G. (1984) The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem. J. 218: 157-163
6. 3H]PSB-298. Purinergic Signalling In press
7. Bertrand, G., Petit, P., Bozem, M., Henquin, J. C. (1989) Membrane and intracellular effects of adenosine in mouse pancreatic betacells. Am. J. Physiol. 257: 473-478
8. Buxton, D. B., Fisher, R. A., Robertson, S. M., Olson, M. S. (1987) Stimulation of glycogenolysis and vasoconstriction by adenosine and adenosine analogues in the perfused rat liver. Biochem. J. 248: 35-41
9. Chapal, J., Loubatieres-Mariani, M. M., Petit, P., Roye, M. (1985) Evidence for an A2-subtype adenosine receptor on pancreatic glucagon secreting cells. Br. J. Pharmacol. 86: 565-569
10. Corssmit, E. P., Romijn, J. A., Enden, E., Sauerwein, H. P. (1994) Pentoxifylline inhibits basal glucose production in humans. J. Appl. Physiol. 77: 2767-2772
11. Gonzalez-Benitez, E., Guinzberg, R., Diaz-Cruz, A., Pina, E. (2002) Regulation of glycogen metabolism in hepatocytes through adenosine receptors. Role of Ca2+ and cAMP. Eur. J. Pharmacol. 437: 105-111
12. Goto, Y., Kakizaki, M., Masaki, N. (1976) Production of spontaneous diabetic rats by repetition of selective breeding. Tohuku J. Exp. Med. 119: 85-90
13. Harada, H., Asano, O., Hoshino, Y., Yoshikawa, S., Matsukura, M., Kabasawa, Y., Niijima, J., Kotake, Y., Watanabe, N., Kawata, T., Inoue, T., Horizoe, T., Yasuda, N., Minami, H., Nagata, K., Murakami, M., Nagaoka, J., Kobayashi, S., Tanaka, I., Abe, S. (2001) 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor. J. Med. Chem. 44: 170-179
14. 2B-selective adenosine receptor antagonists. J. Med. Chem. 45: 1500-1510
15. Hillaire-Buys, D., Bertrand, G., Gross, R., Loubatieres-Mariani, M. M., Ribes, G. (1987) Evidence for an inhibitory Al subtype adenosine receptor on pancreatic insulin-secreting cells [Paradoxical hyperglucagonemia after oral administration of glucose in diabetic dogs. Impact of the cholinergic nervous system]. Eur. J. Pharmacol. 136: 109-112
16. Hillaire-Buys, D., Chapal, J., Bertrand, G., Petit, P., Loubatieres-Mariani, M. M. (1994) Purinergic receptors on insulin-secreting cells. Fundam. Clin. Pharmacol. 8: 117-127
17. 2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J. Med. Chem. 45: 2131-2138
18. 2B adenosine receptor antagonists. 7th International Symposium on Adenosine and Adenine Nucleotides
19. 2B receptor antagonists. J. Med. Chem. 49: 4384-4391
20. Yasuda, N., Inoue, T., Horizoe, T., Nagata, K., Minami, H., Kawata. T., Hoshino, Y., Harada, H., Yoshikawa, S., Asano, O., Nagaoka, J., Murakami, M., Abe, S., Kobayashi, S., Tanaka, I. (2003) Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Eur. J. Pharmacol. 459: 159-166